Supreme Court rejects appeals from drugmakers over Medicare price negotiations

The Supreme Court rejected appeals from pharmaceutical companies regarding Medicare drug price negotiations with the federal government. The decision allows the government to continue negotiating prices. This affects the pharmaceutical industry and Medicare recipients.